Ireland
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 7.20 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
2 |
USD 1.75 B
|
March 31, 2024 | USD 42.18 | 0.76% |
|
Ireland |
|
3 |
USD 1.16 B
|
Dec. 31, 2023 | USD 200.24 | -8.14% |
|
Ireland |
|
4 |
USD 1.15 B
|
Dec. 31, 2023 | USD 93.99 | 0.60% |
|
Ireland |
|
5 |
USD 1.10 B
|
Sept. 30, 2024 | USD 207.57 | 0.10% |
|
Ireland |
|
6 |
USD 1.09 B
|
Dec. 31, 2023 | USD 122.96 | -0.16% |
|
Ireland |
|
7 |
USD 401.35 M
|
Dec. 31, 2023 | USD 28.50 | 0.53% |
|
Ireland |
|
8 |
USD 57.96 M
|
Dec. 31, 2023 | USD 2.05 | 2.67% |
|
Ireland |
|
9 |
USD 37.11 M
|
Dec. 31, 2023 | USD 69.11 | -2.10% |
|
Ireland |
|
10 |
USD 1.23 M
|
Dec. 31, 2023 | USD 0.02 | -6.17% |
|
Ireland |
|
11 |
USD -3.53 M
|
Dec. 31, 2023 | USD 9.02 | 1.18% |
|
Ireland |
|
12 |
USD -33.34 M
|
Dec. 31, 2023 | USD 8.19 | -1.92% |
|
Ireland |
|
13 |
USD -39.33 M
|
Dec. 31, 2023 | USD 1.60 | -2.44% |
|
Ireland |
|
14 |
USD -128.51 M
|
Dec. 31, 2023 | USD 8.05 | 2.94% |
|
Ireland |
|
15 |
USD -133.91 M
|
Dec. 31, 2023 | USD 12.67 | -3.50% |
|
Ireland |
|
16 |
USD -194.25 M
|
Dec. 31, 2023 | USD 3.72 | -0.53% |
|
Ireland |
The Pharmaceuticals company in Ireland with the highest Operating Cash Flow is Medtronic plc (NYSE: MDT) at USD 7.20 B.
The Pharmaceuticals company in Ireland with the lowest Operating Cash Flow is Mural Oncology plc (NasdaqGM: MURA) at USD -194.25 M.
The top 10 Pharmaceuticals companies in Ireland by Operating Cash Flow are Medtronic plc, Experian plc, ICON Public Limited Company, Kerry Group plc, STERIS plc, Jazz Pharmaceuticals plc, Alkermes plc, Uniphar plc, Cosmo Pharmaceuticals N.V. and Ovoca Bio plc.
The bottom 10 Pharmaceuticals companies in Ireland by Operating Cash Flow are Mural Oncology plc, Prothena Corporation plc, Avadel Pharmaceuticals plc, Iterum Therapeutics plc, GH Research PLC, Malin Corporation plc, Ovoca Bio plc, Cosmo Pharmaceuticals N.V., Uniphar plc and Alkermes plc.